(Q39985508)

English

Interfering with cellular signaling pathways enhances sensitization to combined sodium butyrate and GCV treatment in EBV-positive tumor cells

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Interfering with cellular signaling pathways enhances sensitization to combined sodium butyrate and GCV treatment in EBV-positive tumor cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Yuwen He

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Shaohui Cai

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Ge Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Xiaoqing Li

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Liting Pan

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Jun Du

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

2 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

135

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

175-180

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Prospects for anti-ras drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Methylglyoxal downregulates Raf-1 protein through a ubiquitination-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Short-chain fatty acids inhibit invasive human colon cancer by modulating uPA, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax, p21 and PCNA protein expression in an in vitro cell culture model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Transcription factor ATF2 regulation by the JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Characterization of the Epstein-Barr virus BALF2 promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Virally targeted therapies for EBV-associated malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Ras/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retinoic acid and 9-(2-hydroxyethoxymethyl) guanine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Immunological response of nasopharyngeal carcinoma patients to the Epstein-Barr-virus-coded thymidine kinase expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Function and regulation of ras.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

DNA damage-induced cell death by apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt's lymphoma cell lines versus B lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Activation of latent Epstein–Barr virus by antibody to human IgM

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Use of antigen expressed in bacteria for detection of EBV-specific thymidine kinase antibodies in sera from patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Epstein-Barr virus: 40 years on

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.03.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIRUSRES.2008.03.012

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39985508&oldid=1881731691"